Fed. Circ. In September: The Printed Matter Doctrine Expands
This article is part of a monthly column that highlights an important patent appeal from the previous month. In this installment, we examine the Federal Circuit's ruling in Bayer Pharma Aktiengesellschaft v. Mylan Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article